© 1996 Oxford University Press
research-article |
Chemically induced lung and forestomach neoplasias in transgenic mice carry mutant forms of the human c-Ha-ras transgene
Department of Pathology, Nagoya City University Medical School 1 Kawasumi, Mizuho-cho, Mizuho-ku, Nagoya 467
1Laboratory of Pathology, Aichi Cancer Research Institute 1-1 Kanokoden, Chikusa-ku, Nagoya 464, Japan
2To whom correspondence should be addressed
Susceptibility to lung carcinogens and genetic changes in neoplastic lesions were investigated in transgenic mice carrying a human hybrid c-Ha-ras gene, encoding a prototype p21 gene product. Nine-week-old male and female transgenic mice and non-transgenic littermates were injected i.p. with 6-nitrochrysene (6NC) three times biweekly or administerted urethane in their drinking water for 3 weeks. Control mice were given dimethylsulfoxide(DMSO), the solvent for 6NC,alone. The incidences of lung adenocarcinomas were four out of seven female (57%)transgenic mice treated with 6NC and three out of three males (100%) and three out of three females (100%) receiving urethane. No adenocarcinomas were observed in control animals or non-transgenic mice. Adenomas developed in all treated groups, but the incidence and multiplicity were higher in transgenic animals than in their non-transgenic counterparts. In the 6NC-treated group, forestomach papillomas and squamous cell carcinomas were also observed in both male (25 and 50%) and female (56 and 33%) transgenic mice. PCR-SSCP and DNA sequence analysis of these induced lesions revealed point mutations at codon 61 of transgenic human c-Ha-ras, from CAG (Gin) to CTG (Leu) or CAG (Gin) to AAG (Lyn) in lung hyperplasias (two out of three), an adenoma (one out of two), adenocarcinomas (five out of seven) and forestomach squamous cell carcinomas (four out of five). Mutations were not observed in forestomach papillomas. No changes in mouse Ha-ras or KI-ras were found in any lesions. Furthermore, p21 overexpression was not evident in lung or forestomach tumors on immunohistochemical analysis. These findings indicate a high sensitivity to lung carcinogens in transgenicmice carrying the human c-Ha-ras gene and that this might be effected by mutational activation.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Ozaki, K. Ozaki, T. Watanabe, S. Uwagawa, Y. Okuno, and T. Shirai Susceptibilities of p53 Knockout and rasH2 Transgenic Mice to Urethane-Induced Lung Carcinogenesis are Inherited from their Original Strains Toxicol Pathol, February 1, 2005; 33(2): 267 - 271. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-M. Hayashi, H.-H. L. Hong, K. Toyoda, T.-V. T. Ton, T. R. Devereux, R. R. Maronpot, J. Huff, and R. C. Sills High Frequency of Ras Mutations in Forestomach and Lung Tumors of B6C3F1 Mice Exposed to 1-Amino-2,4-dibromoanthraquinone for 2 Years Toxicol Pathol, June 1, 2001; 29(4): 422 - 429. [Abstract] [PDF]
|
|
|
|
|
|
N. Tamaoki The rasH2 Transgenic Mouse: Nature of the Model and Mechanistic Studies on Tumorigenesis Toxicol Pathol, January 1, 2001; 29(1_suppl): 81 - 89. [Abstract] [PDF]
|
|
|
|
|
|
K. Mitsumori, H. Koizumi, T. Nomura, and S. Yamamoto Pathological Features of Spontaneous and Induced Tumors in Transgenic Mice Carrying a Human Prototype c-Ha-ras Gene Used for Six-Month Carcinogenicity Studies Toxicol Pathol, July 1, 1998; 26(4): 520 - 531. [Abstract] [PDF]
|
|
|
|
|
|
S.-m. Hayashi, I. Mori, T. Nonoyama, and K. Mitsumori Point Mutations of the c-H-ras Gene in Spontaneous Liver Tumors of Transgenic Mice Carrying the Human c-H-ras Gene Toxicol Pathol, July 1, 1998; 26(4): 556 - 561. [Abstract] [PDF]
|
|